A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.
about
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@ast
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@en
type
label
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@ast
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@en
prefLabel
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@ast
A metastatic colon adenocarcin ...... b/trametinib and chemotherapy.
@en
P2093
P2860
P356
P1476
A metastatic colon adenocarcin ...... ib/trametinib and chemotherapy
@en
P2093
Brian Leyland-Jones
Caitlin McMahon
Casey B Williams
Deborah Morosini
Doron Lipson
Heidi McKean
Jeffrey S Ross
Jessica Klein
Julia A Elvin
Juliann Chmielecki
P2860
P304
P356
10.2147/OTT.S90766
P407
P577
2015-12-01T00:00:00Z